These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16314189)

  • 1. Remission of severe relapsing or persistent lupus nephritis using mycophenolate mofetil.
    Flores-Suárez LF
    Arch Med Res; 2006 Jan; 37(1):68-73. PubMed ID: 16314189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
    Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
    Chan TM; Tse KC; Tang CS; Mok MY; Li FK;
    J Am Soc Nephrol; 2005 Apr; 16(4):1076-84. PubMed ID: 15728784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
    Ong LM; Hooi LS; Lim TO; Goh BL; Ahmad G; Ghazalli R; Teo SM; Wong HS; Tan SY; Shaariah W; Tan CC; Morad Z
    Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Lupus; 2015 Dec; 24(14):1520-8. PubMed ID: 26162684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
    Wang J; Hu W; Xie H; Zhang H; Chen H; Zeng C; Liu Z; Li L
    Lupus; 2007; 16(9):707-12. PubMed ID: 17728363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil for remission induction in severe lupus nephritis.
    Cross J; Dwomoa A; Andrews P; Burns A; Gordon C; Main J; Mathieson P; O'Donoghue D; Jayne D;
    Nephron Clin Pract; 2005; 100(3):c92-100. PubMed ID: 15824513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can mycophenolate mofetil substitute cyclophosphamide treatment of pediatric lupus nephritis?
    Paredes A
    Pediatr Nephrol; 2007 Aug; 22(8):1077-82. PubMed ID: 17370094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
    N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?
    Rovin BH; Parikh SV; Hebert LA; Chan TM; Mok CC; Ginzler EM; Hooi LS; Brunetta P; Maciuca R; Solomons N
    Clin J Am Soc Nephrol; 2013 Jan; 8(1):147-53. PubMed ID: 22879439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis.
    Kasitanon N; Fine DM; Haas M; Magder LS; Petri M
    Lupus; 2006; 15(6):366-70. PubMed ID: 16830883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lupus nephritis by mycophenolate mofetil.
    Rabrenović V; Poskurica M; Kovacević Z; Nesić V; Savin M; Mitić B; Dimković N; Cucković C; Vujić D; Pljesa S; Perunicić-Peković G; Curić S; Mitić I; Ratković M; Marinković J; Jovanović D
    Kidney Blood Press Res; 2010; 33(4):297-303. PubMed ID: 20664209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mycophenolate mofetil for patients with crescentic lupus nephritis.
    Tang Z; Yang G; Yu C; Yu Y; Wang J; Hu W; Zeng C; Chen H; Liu Z; Li L
    Nephrology (Carlton); 2008 Dec; 13(8):702-7. PubMed ID: 18771470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rescue therapy in lupus nephritis patients with mycophenolate mofetil].
    Pretini VB; Avila López GE; Sesín AM; Dotto BH; Sanchez Freytes M; Sesín J; Vergottini JC
    Rev Fac Cien Med Univ Nac Cordoba; 2006; 63(3):39-46. PubMed ID: 17639816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS).
    Sinclair A; Appel G; Dooley MA; Ginzler E; Isenberg D; Jayne D; Wofsy D; Solomons N
    Lupus; 2007; 16(12):972-80. PubMed ID: 18042591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
    Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mycophenolate mofetil maintenance therapy in lupus nephritis].
    Milewski M; Jakieła B; Zółciński M; Chmielewska A; Musiał J
    Pol Arch Med Wewn; 2006 Oct; 116(4):947-54. PubMed ID: 18416296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential therapies for proliferative lupus nephritis.
    Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
    N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil.
    Daleboudt GM; Reinders ME; den Hartigh J; Huizinga TW; Rabelink AJ; de Fijter JW; Berger SP
    Lupus; 2013 Feb; 22(2):171-9. PubMed ID: 23257398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.